CN1972927A - 用于治疗血脂障碍的化合物和方法 - Google Patents

用于治疗血脂障碍的化合物和方法 Download PDF

Info

Publication number
CN1972927A
CN1972927A CNA2005800207650A CN200580020765A CN1972927A CN 1972927 A CN1972927 A CN 1972927A CN A2005800207650 A CNA2005800207650 A CN A2005800207650A CN 200580020765 A CN200580020765 A CN 200580020765A CN 1972927 A CN1972927 A CN 1972927A
Authority
CN
China
Prior art keywords
trifluoromethyl
alkyl
amino
dihydro
tetrazolium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800207650A
Other languages
English (en)
Chinese (zh)
Inventor
A·M·埃斯克里瓦诺
M·C·费尔南德斯
N·B·曼特欧
A·I·马特奥-赫兰斯
E·M·马丁德拉纳瓦
王晓冬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1972927A publication Critical patent/CN1972927A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800207650A 2004-06-24 2005-06-22 用于治疗血脂障碍的化合物和方法 Pending CN1972927A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58270804P 2004-06-24 2004-06-24
US60/582,708 2004-06-24
US60/627,241 2004-11-12
US60/664,862 2005-03-24

Publications (1)

Publication Number Publication Date
CN1972927A true CN1972927A (zh) 2007-05-30

Family

ID=38113143

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800207650A Pending CN1972927A (zh) 2004-06-24 2005-06-22 用于治疗血脂障碍的化合物和方法

Country Status (3)

Country Link
CN (1) CN1972927A (ru)
UA (1) UA89046C2 (ru)
ZA (1) ZA200610093B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102639528A (zh) * 2009-06-30 2012-08-15 伊莱利利公司 反式-4-[[(5s)s-[[[3，5-双(三氟甲基)苯基]甲基](2-甲基-2h-四唑-5-基)氨基]-2，3，4，5-四氢-7，9-二甲基-1h-1-苯并氮杂*-1-基]甲基]-环己烷羧酸

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102639528A (zh) * 2009-06-30 2012-08-15 伊莱利利公司 反式-4-[[(5s)s-[[[3，5-双(三氟甲基)苯基]甲基](2-甲基-2h-四唑-5-基)氨基]-2，3，4，5-四氢-7，9-二甲基-1h-1-苯并氮杂*-1-基]甲基]-环己烷羧酸
CN102639528B (zh) * 2009-06-30 2014-07-16 伊莱利利公司 反式-4-[[(5s)-5-[[[3，5-双(三氟甲基)苯基]甲基](2-甲基-2h-四唑-5-基)氨基]-2，3，4，5-四氢-7，9-二甲基-1h-1-苯并氮杂*-1-基]甲基]-环己烷羧酸

Also Published As

Publication number Publication date
ZA200610093B (en) 2008-02-27
UA89046C2 (ru) 2009-12-25

Similar Documents

Publication Publication Date Title
CN105814067B (zh) 作为钠通道调节剂的吡啶酮酰胺的前药
CN1759114B (zh) 作为细胞因子抑制剂的杂环n-芳基甲酰胺
CN1910154B (zh) 用作分枝杆菌抑制剂的喹啉衍生物
CN1972932B (zh) 治疗血脂障碍的化合物
CN101821266B (zh) 囊性纤维化跨膜通道调节因子的调节剂
CN100415724C (zh) 嘧啶衍生物
CN106220644B (zh) 稠环嘧啶氨基衍生物﹑其制备方法、中间体、药物组合物及应用
CN101778831B (zh) 哌嗪酰胺衍生物
CN101268048A (zh) 咔唑衍生物
CN101243073A (zh) 5－ht1a受体的哌嗪－哌啶拮抗剂与激动剂
CN102762570A (zh) 作为jak抑制剂的吡唑衍生物
CN102395576A (zh) 调控jak激酶的喹唑啉衍生物和其使用方法
CN106795165B (zh) 咪唑并哒嗪化合物
CN102838546A (zh) 作为5-ht2a 血清素受体调节剂用于治疗与其相关病症的吡唑衍生物
CN102485721A (zh) 取代的2,3-二氮杂萘酮化合物及其用途
HUE028391T2 (en) Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
CN1414953A (zh) 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和5－羟色胺重摄取的用途
CN105121439A (zh) 作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
CN101679273A (zh) 1位取代的四氢异喹啉化合物
CN101605767A (zh) 制备哌嗪基苯甲酰胺衍生物和二氮杂环庚烷基苯甲酰胺衍生物的方法
CN101730680A (zh) 具有5-ht6受体亲和力的4’取代的化合物
CN100430383C (zh) 可用于治疗性功能障碍的苯并咪唑
CN106854207A (zh) 呔嗪类衍生物、其制备方法、药物组合物和用途
CN102781914B (zh) 吲哚衍生物
JPH10500674A (ja) ５ｈｔ▲下１ａ▼および５ｈｔ▲下１ｄ▼拮抗薬含有組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070530